Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

WENGER

Showing results (401-410 of 5,435) with videos related to

Pageof 544
Sort By:
The American Journal of Geriatric Cardiology|October 1, 1996
Hormone Replacement Therapy in Postmenopausal Women: Does It Lessen Coronary Heart Disease Risk?Nanette K. Wenger
Diabetes, Obesity & Metabolism|June 6, 2002
Cardiovascular effects of raloxifene: the potential for cardiovascular protection in womenN K Wenger
Annals of Internal Medicine|February 1, 1976
Cardiac rehabilitation: the United Kingdom and the United StatesN K Wenger
Cardiology in Review|July 30, 2002
Coronary heart disease and women: magnitude of the problemNanette K Wenger
Archives of Neurology|March 1, 1984
The brain in Gaucher's diseaseD A Wenger
Journal of the Medical Association of Georgia|February 1, 1983
Thrombolytic therapy in the management of venous thromboembolismN K Wenger
JACC. Case Reports|July 28, 2021
Why Are We Not There Yet?Nanette K Wenger
Pharmacology, Biochemistry, and Behavior|November 1, 1980
Cumulative dose-response curves in behavioral pharmacologyG R Wenger
Cardiology in Review|December 20, 2007
Exploring sex/gender differences in women's cardiovascular healthNanette K Wenger
Cardiology in Review|December 20, 2007
Women, their age, and their cholesterol valuesNanette K Wenger
Pageof 544

Showing results (401-410 of 5,435) with videos related to

Sort By:
Pageof 544
The American Journal of Geriatric Cardiology|October 1, 1996
Hormone Replacement Therapy in Postmenopausal Women: Does It Lessen Coronary Heart Disease Risk?Nanette K. Wenger
Diabetes, Obesity & Metabolism|June 6, 2002
Cardiovascular effects of raloxifene: the potential for cardiovascular protection in womenN K Wenger
Annals of Internal Medicine|February 1, 1976
Cardiac rehabilitation: the United Kingdom and the United StatesN K Wenger
Cardiology in Review|July 30, 2002
Coronary heart disease and women: magnitude of the problemNanette K Wenger
Archives of Neurology|March 1, 1984
The brain in Gaucher's diseaseD A Wenger
Journal of the Medical Association of Georgia|February 1, 1983
Thrombolytic therapy in the management of venous thromboembolismN K Wenger
JACC. Case Reports|July 28, 2021
Why Are We Not There Yet?Nanette K Wenger
Pharmacology, Biochemistry, and Behavior|November 1, 1980
Cumulative dose-response curves in behavioral pharmacologyG R Wenger
Cardiology in Review|December 20, 2007
Exploring sex/gender differences in women's cardiovascular healthNanette K Wenger
Cardiology in Review|December 20, 2007
Women, their age, and their cholesterol valuesNanette K Wenger
Pageof 544